Dyne Therapeutics Inc header image

Dyne Therapeutics Inc

DYN

Equity

ISIN null / Valor 56806425

NASDAQ (2026-10-05)

USD 15.44+1.58%

Dyne Therapeutics Inc
UMushroom community rating:

2.50 2 votes No rating yet

NegativeNeutralPositive

About company

Dyne Therapeutics Inc is a biotechnology firm dedicated to developing innovative treatments for serious muscle diseases. Leveraging its proprietary FORCE™ platform, the company aims to address the challenges associated with delivering therapeutics to muscle tissue, focusing on the advancement of oligonucleotide therapeutic candidates. Founded with a clear mission to transform the lives of those afflicted by muscle diseases, Dyne has built a robust team with extensive expertise in muscle disease, rare disorders, drug development, manufacturing, and the commercialization of novel therapeutics. Additionally, the company benefits from the guidance of a scientific advisory board composed of renowned experts in muscle disease drug discovery, development, and nucleic acid therapeutics, underscoring its commitment to pioneering breakthroughs in the field.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

18.2%1Y

63.6%3Y

-1.91%5Y

Performance

73.5%1Y

83.1%3Y

79.3%5Y

Volatility

2883 M

Market cap (USD)

4,377,364

Daily traded volume (Shares)

24 / 23.14

1 day high/low (USD)

0.00 / 0.00

52 weeks high/low (USD)

01 January, 2022

Dividend ex-date

0.00

Dividend (USD)

0.00%

Dividend yield (p.a.)

0.002022

0.002023

0.002024

Est dividend (USD)

0.00%2022

0.00%2023

0.00%2024

Est dividend yield

10.00

P/E ratio

00.002022

00.002023

00.002024

Est P/E ratio

0.00

EPS (USD)

0.002022

0.002023

0.002024

Est EPS (USD)

Ratings & reviews

2.50

2 votes

Performance:

2.50

Innovation:

2.50

Society:

2.50

Nature:

2.50

Rex Kong

Malaysia, 30 Apr 2026

It’s average

Han Yee Kong

Malaysia, 30 Apr 2026

.

EQUITIES OF THE SAME SECTOR

UCB SA

UCB SA Valor: 986410

Annual Return

-50%0%+50%

Risk level

110

-1.66%EUR 200.90

Oncopeptides AB

Oncopeptides AB Valor: 35671972

Annual Return

-50%0%+50%

Risk level

110

-2.18%SEK 2.06

Fagron SA

Fagron SA Valor: 3425437

Annual Return

-50%0%+50%

Risk level

110

0.67%EUR 22.65

Alembic Pharmaceuticals Limited

Alembic Pharmaceuticals Limited Valor: 11500585

Annual Return

-50%0%+50%

Risk level

110

1.98%INR 831.15

Coloplast A/S

Coloplast A/S Valor: 20259063

Annual Return

-50%0%+50%

Risk level

110

-0.61%DKK 410.00

Vitrolife AB

Vitrolife AB Valor: 41707777

Annual Return

-50%0%+50%

Risk level

110

-2.34%SEK 89.65

H. Lundbeck A/S

H. Lundbeck A/S Valor: 119252587

Annual Return

-50%0%+50%

Risk level

110

1.10%DKK 44.16

L'Oreal S.A.

L'Oreal S.A. Valor: 502805

Annual Return

-50%0%+50%

Risk level

110

0.19%EUR 373.45

Apollo Hospitals Enterprise Limited

Apollo Hospitals Enterprise Limited Valor: 11650098

Annual Return

-50%0%+50%

Risk level

110

-1.31%INR 8,010.00

Sanofi SA

Sanofi SA Valor: 699381

Annual Return

-50%0%+50%

Risk level

110

-1.16%EUR 69.99

SIX

FactSet

Clearbit

Logos provided by Clearbit